These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11741245)

  • 1. Assessing the cost-effectiveness of pharmacogenomics.
    Veenstra DL; Higashi MK; Phillips KA
    AAPS PharmSci; 2000; 2(3):E29. PubMed ID: 11741245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cost-effectiveness analysis in the era of pharmacogenomics.
    Flowers CR; Veenstra D
    Pharmacoeconomics; 2004; 22(8):481-93. PubMed ID: 15217305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.
    van den Akker-van Marle ME; Gurwitz D; Detmar SB; Enzing CM; Hopkins MM; Gutierrez de Mesa E; Ibarreta D
    Pharmacogenomics; 2006 Jul; 7(5):783-92. PubMed ID: 16886902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research advances in pharmacogenomics of mercaptopurine].
    Chen XX; Shen SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Sep; 19(9):1027-1033. PubMed ID: 28899477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic opportunities and challenges for pharmacogenomics.
    Deverka PA; Vernon J; McLeod HL
    Annu Rev Pharmacol Toxicol; 2010; 50():423-37. PubMed ID: 20055709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
    Rioux PP
    Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost effectiveness analysis of thiopurine methyltransferase testing for guiding 6-mercaptopurine dosing in children with acute lymphoblastic leukemia.
    Donnan JR; Ungar WJ; Mathews M; Hancock-Howard RL; Rahman P
    Pediatr Blood Cancer; 2011 Aug; 57(2):231-9. PubMed ID: 21344614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the genetics revolution for health services research: pharmacogenomics and improvements in drug therapy.
    Phillips KA; Veenstra DL; Sadee W
    Health Serv Res; 2000 Dec; 35(5 Pt 3):128-40. PubMed ID: 16148957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of genotyping to guide treatment.
    Sorich MJ; Wiese MD; Pekarsky B
    Pharmacogenomics; 2014 Apr; 15(6):727-9. PubMed ID: 24897279
    [No Abstract]   [Full Text] [Related]  

  • 11. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
    Karas-Kuzelicki N; Mlinaric-Rascan I
    Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics.
    Phillips KA; Veenstra D; Van Bebber S; Sakowski J
    Pharmacogenomics; 2003 May; 4(3):231-9. PubMed ID: 12718713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacogenomics in routine medical care].
    Rosskopf D; Meyer zu Schwabedissen HE; Kroemer HK; Siegmund W
    Dtsch Med Wochenschr; 2010 Jan; 135(4):133-44; quiz 145-6. PubMed ID: 20101557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics, cost of genotyping, and guidelines for individualizing therapy with mercaptopurine in pediatric acute lymphoblastic leukemia.
    Stocco G; Crews KR
    Pediatr Blood Cancer; 2011 Dec; 57(7):1247. PubMed ID: 21796762
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics: the promise of personalized medicine.
    Hood E
    Environ Health Perspect; 2003 Aug; 111(11):A581-9. PubMed ID: 12928155
    [No Abstract]   [Full Text] [Related]  

  • 16. The Relationship of Genetics, Nursing Practice, and Informatics Tools in 6-Mercaptopurine Dosing in Pediatric Oncology [Formula: see text].
    Haylett WJ
    J Pediatr Oncol Nurs; 2017; 34(5):342-346. PubMed ID: 28681659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-guided warfarin therapy: current status.
    Tavares LC; Marcatto LR; Santos PCJL
    Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current pharmacogenomic approaches to clinical drug development.
    Murphy MP
    Pharmacogenomics; 2000 May; 1(2):115-23. PubMed ID: 11256585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic evaluation of warfarin pharmacogenomics.
    You JH
    Expert Opin Pharmacother; 2011 Feb; 12(3):435-41. PubMed ID: 21231897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular pharmacogenomics].
    Ahlehoff O; Hansen PR
    Ugeskr Laeger; 2009 Apr; 171(17):1405-7. PubMed ID: 19413939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.